GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
IM-L 20-001_000 Photanol Productie van organisch zuur met cyanobacteriën Ontwerpbesluit genomen
IM-MV 19-002_004 Universitair Medisch Centrum Utrecht Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells 22-03-2021 Vergunning verleend
IM-MV 19-011_004 Erasmus MC Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells 22-03-2021 Vergunning verleend
IM-MV 19-014_004 UMCG Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells 22-03-2021 Vergunning verleend
IM-MV 20-015_000 AMC A Clinical Study to Evaluate the Safety, Reactogenicity, Immunogenicity and Efficacy of an Ad26 and/or MVA-BN clinical vector for the prevention or treatment of infectious diseases 01-04-2021 Vergunning verleend
IM-MV 20-018_000 LUMC Exposure of human test subjects to live genetically attenuated PfDmei2 (LA-GAP) malaria parasites 04-02-2021 Vergunning verleend
IM-MV 20-019_000 Stichting Katholieke Universiteit Exposure of human test subjects to live genetically attenuated PfDmei2 (LA-GAP) malaria parasites 08-02-2021 Vergunning verleend
IM-MV 20-020_000 Intervet International Ontwikkeling van een levend vaccin tegen Histophilus luchtweginfecties in kalveren 16-03-2021 Vergunning verleend
IM-MV 21-002_000 Intervet International Vaccinatie van kippen met een recombinant herpes virus of turkey met een of meerdere inserties van het F gen van Newcastle disease virus, het VP2 gen van Infectious bursal disease virus en/of de glycoproteïnes I en D van Infectious laryngotracheitis virus Ontwerpbesluit genomen